The Cytel Blog: Perspectives on Enquiry & Evidence

As more payers and HTA agencies turn to real world data to compare the effectiveness of various treatment effects, two..

Two therapies are placed in head-to-head clinical trials when they are compared against each other as opposed to a..

Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the..

Former Commissioner of the FDA, Dr. Scott Gottlieb, in several public presentations, would bemoan missed chances to..

In recent times, Single arm trials are being increasingly used to assess new treatment interventions. They establish..

Recent years have witnessed improving survival outcomes for those struggling with a range of common kidney cancers...

COVID-19 has transformed the pharmaceutical industry in a manner that few could have predicted only a year ago. One of..

Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR..

  As a part of Cytel’s "New Horizons Webinar Series", Alind Gupta, Senior Data Scientist, presents case studies from..